Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
March-2017 Volume 39 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March-2017 Volume 39 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Morroniside protects SK-N-SH human neuroblastoma cells against H2O2-induced damage

Corrigendum in: /10.3892/ijmm.2025.5501
  • Authors:
    • Jing-Xing Zhang
    • Rui Wang
    • Jin Xi
    • Lin Shen
    • An-You Zhu
    • Qi Qi
    • Qi-Yi Wang
    • Lun-Jun Zhang
    • Feng-Chao Wang
    • He-Zuo Lü
    • Jian-Guo Hu
  • View Affiliations / Copyright

    Affiliations: Department of Clinical Laboratory, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233004, P.R. China, Anhui Key Laboratory of Tissue Transplantation, Bengbu Medical College, Bengbu, Anhui 233004, P.R. China
    Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 603-612
    |
    Published online on: February 8, 2017
       https://doi.org/10.3892/ijmm.2017.2882
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Oxidative stress-induced cell injury has been linked to the pathogenesis of neurodegenerative disorders such as spinal cord injury, Parkinson's disease, and multiple sclerosis. Morroniside is an antioxidant derived from the Chinese herb Shan-Zhu-Yu. The present study investigated the neuroprotective effect of morroniside against hydrogen peroxide (H2O2)-induced cell death in SK-N-SH human neuroblastoma cells. H2O2 increased cell apoptosis, as determined by flow cytometry and Hoechst 33342 staining. This effect was reversed by pretreatment with morroniside at concentrations of 1-100 µM. The increase in intracellular reactive oxygen species (ROS) generation and lipid peroxidation induced by H2O2 was also abrogated by morroniside. H2O2 induced a reduction in mitochondrial membrane potential, increased caspase-3 activity, and caused downregulation of B cell lymphoma-2 (Bcl-2) and upregulation of Bcl-2-associated X protein (Bax) expression. These effects were blocked by morroniside pretreatment. Thus, morroniside protects human neuroblastoma cells against oxidative damage by inhibiting ROS production while suppressing Bax and stimulating Bcl-2 expression, thereby blocking mitochondrial-mediated apoptosis. These results indicate that morroniside has therapeutic potential for the prevention and treatment of neurodegenerative diseases.

Introduction

Neurodegenerative disorders are characterized by loss or dysfunction of neurons in the central nervous system (1,2). Oxidative stress and consequent mitochondrial dysfunction contribute to the pathology of spinal cord injury (3,4), stroke (5,6), Parkinson's disease (7), and Alzheimer's disease (8) via production of reactive oxygen species (ROS), which include hydrogen peroxide (H2O2), superoxide, singlet oxygen, and the hydroxyl radical (9).

ROS play an important role in intracellular signal transduction and gene expression in cell survival and organism development (10). However, excess accumulation of ROS can damage proteins, DNA and cell membranes (11). ROS induce cell death via the mitochondrial apoptosis pathway (12). Neurons are thought to be more susceptible to ROS owing to increased oxidative metabolism and fewer antioxidative enzymes (13,14). Suppression of ROS generation and inhibition of apoptosis can therefore potentially prevent neurodegeneration.

Cornus officinalis is among the most commonly used Chinese medical herbs and has been used to treat kidney- and brain-related diseases (15). Its biological activities include antioxidant (16,17), anti-inflammatory (18) and antimicrobial (19) effects. Morroniside is the major active ingredient of C. officinalis extract (20) (Fig. 1) and has been shown to reduce blood glucose, mitigate cerebral ischemia-reperfusion injury, and modulate the immune response (21). However, little is known concerning the effects of morroniside on oxidative stress-induced cell damage.

Figure 1

Chemical structure of morroniside.

Materials and methods

Cell culture and treatment

SK-N-SH human neuroblastoma cells (Type Culture Collection of the Chinese Academy of Sciences, Shanghai, China) were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (v/v) fetal bovine serum, 100 U/ml penicillin/streptomycin (all from Invitrogen, Carlsbad, CA, USA) in plastic 25-cm2 flasks at 37°C and under 5% CO2, 95% air. Culture medium was changed every other day and the cells were subcultured once attaining 70–80% confluency. Morroniside (Phytomarker Ltd., Tianjin, China) was dissolved in D-PBS (Invitrogen) and H2O2 (Sinopharm Chemical Reagent Co. Ltd., Shanghai, China) was dissolved in sterile distilled water. SK-N-SH cells were pretreated with different concentrations of morroniside for 24 h, followed by incubation with H2O2 (200–400 µM) for 24 h to induce injury.

Cell viability assay

The viability of the cells was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Briefly, SK-N-SH cells were plated into 96-well plates at the density of 5×103 cells/well. Cells were preincubated with morroniside (1, 10 and 100 µM) for 24 h before 200 µM H2O2 was administered. After a 24-h incubation, 20 µl of a 5 mg/ml stock solution of MTT (Sigma, St. Louis, MO, USA) was added to the culture medium and incubated in the dark for 4 h at 37°C to allow for formazan formation. Then MTT formazan crystals were dissolved in 100 µl dimethyl sulfoxide (DMSO; Sigma) and spectrophotometrically determined at an absorbance of 570 nm. The percentage of cell viability was measured by normalization of all values to the control group (=100%).

Morphological observation

SK-N-SH cells were seeded into 6-well plates at the density of 2×105 cells/well. When cell confluency achieved 70–80%, the cells were pre-incubated with morroniside for 24 h before H2O2 (200 µM) was added to induce cell damage for another 24 h. The growth and morphological changes in each group were observed under an inverted phase contrast microscope.

Cytotoxicity assay

Lactate dehydrogenase (LDH) assay was used to assay H2O2-induced cytotoxicity. SK-N-SH cells were seed into 96-well plates at a density of 5×103 cells/well. After cells were exposed to H2O2 (200 µM) for 24 h, a total of 120 µl of cell medium was collected for LDH analysis according to the manufacturer's protocol included in the cytotoxicity assay kit (Beyotime Biotechnology, Nantong, China). The absorbance of each group was read at 490 nm. Each group had five duplicate wells and the experiments were repeated at least three times. Data are expressed as the percentage of LDH release of the injury group (H2O2-induced group).

Apoptosis analysis

In order to determine whether morroniside protects against H2O2-induced apoptosis, Hoechst 33342 (Sigma), a fluorescent nuclear dye, was used to detect cell apoptosis by observing the cell morphology. Briefly, SK-N-SH cells were treated as described above and then washed with phosphate-buffered saline (PBS) and incubated with Hoechst 33342 (10 µg/ml in PBS; Sigma) for 15 min at 37°C in the dark. The cells were washed with PBS, fixed with cold 4% paraformaldehyde for another 15 min in room temperature, washed with PBS again, and then examined by fluroescence microscopy. The percentage of apoptotic cells was calculated as the ratio of apoptotic cells to the total cells counted. At least 500 cells were counted from more than 3 random microscopic fields.

Moreover, in order to confirm the anti-apoptotic effect of morroniside, flow cytometry with Annexin V-FITC and propidium iodide (PI) double staining (Beyotime Biotechnology) was performed. After SK-N-SH cells were treated with H2O2 (200 µM), 5×105 cells were collected and counted for Annexin V-FITC and PI double staining. Briefly, cells in different groups were washed three times with cold PBS and stained with Annexin V-FITC for 15 min in the dark. After cells were washed another three times, PI was added and the fluorescence of each group was immediately analyzed by flow cytometry.

Assessment of intracellular ROS production

For visualization and analysis of intracellular ROS, the oxidation sensitive probe DCFH-DA (Beyotime Biotechnology) was used. After the treatment of H2O2, SK-N-SH cells were exposed to 10 µM DCFH-DA for 20 min at 37°C in the dark. The cells were washed with PBS for 3 times, and then DCF fluorescence was observed using fluorescence microscopy and quantified by fluorescence multi-well plate reader (BioTek, Highland Park, VT, USA) with an excitation wavelength of 488 nm and emission wavelength of 525 nm.

Measurement of intracellular superoxide anion production

Superoxide anion was detected with dihydroethidium probes. Cells were treated with 2 µM dihydroethidium (Beyotime Biotechnology) for 30 min at 37°C in dim light after incubation with H2O2. Each well was washed with cold PBS and then DMEM to remove the remaining probes. Then cells were observed using fluorescence microscopy and the fluorescence intensity was quantified by a fluorescence multi-well plate reader.

Lipid peroxidation assay

Lipid peroxidation was monitored by measuring malondiadehyde (MDA; Beyotime Biotechnology), a stable end product of lipid peroxidation cascades using an MDA assay kit. SK-N-SH cells were washed with ice-cold PBS and then harvested with RIPA lysis buffer (Beyotime Biotechnology) after the treatment of H2O2. Cell homogenates were centrifuged at 16,000 × g at 4°C for 10 min. The supernatant was used for MDA assay and protein determination. The total protein concentrations were measured using BCA Protein assay kit (Beyotime Biotechnology). For MDA measurement, 100 µl samples were added into a 15-ml tube followed by addition of 200 µl MDA working solution. The mixture was heated at 100°C for 15 min, chilled to room temperature, and centrifuged at 1,000 × g for 10 min. Supernatants of 200 µl were transferred to 96-well plates, and the absorbance of each group was read at 532 nm.

Determination of activity of superoxide dismutase (SOD)

Cellular SOD levels were determined using a Superoxide Dismutase assay kit (Jiancheng Bioengineering Institute, Nanjing, China). SK-N-SH cells were pretreated with different concentrations of morroniside for 24 h prior to exposure to H2O2 (200 µM) for another 24 h. Cells were washed twice with ice-cold PBS and harvested in RIPA lysis buffer, and then total protein contents were determined with the BCA protein assay kit (Beyotime Biotechnology). Samples were collected and analyzed according to the manufacturer's instructions. SOD levels were normalized to the protein concentrations.

Monitoring mitochondrial membrane potential (MMP)

SK-N-SH cells were treated with various dose of morroniside in a 12-well plate for 24 h before H2O2 (200 µM) for 24 h. A fluorescent dye JC-1 (Beyotime Biotechnology) was added to achieve final concentration of 10 µg/ml. Then cells were incubated for 30 min at 37°C in dim light. Cells were washed with PBS to remove the excess dye, and then images were captured using fluorescence microscopy within 30 min. For the JC-1 monomer, excitation wavelength was 514 nm and maximum emission wavelength was 529 nm. For the JC-1 polymer, the maximum excitation and emission wavelength were 585 and 590 nm, respectively.

Measurement of caspase-3 activity

Activity of caspase-3 was measured with a commercial caspase-3 activity assay kit (Beyotime Biotechnology), using Ac-DEVD-pNA as the specific substrate. The cell pellets were lysed on ice in lysis buffer for 15 min, and then the lysate was centrifuged at 20,000 × g for 10 min at 4°C. Supernatant of 10 µl was collected and incubated with 10 µl Ac-DEVD-pNA (2 mM) at 37°C for another 1–2 h in the dark. The absorbance values were measured with a spectrofluorometer at 405 nm and were corrected as protein content in the lysate. Protein concentration was determined by Bradford protein assay kit (Beyotime Biotechnology) according to the manufacturer's instructions.

Reverse transcription-polymerase chain reaction (RT-PCR)

The mRNA expression levels of B cell lymphoma-2 (Bcl-2) and Bcl-2-associated X protein (Bax) were determined by RT-PCR. Briefly, SK-N-SH cells were treated as mentioned above, and the total RNA of each group was extracted using TRIzol agent (Invitrogen) according to the manufacturer's instructions. Two micrograms of total RNA was first reverse transcribed into cDNA, and then routine PCR was performed as previously described (22). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as an internal control and products were analyzed on 1% agarose gel. ImageJ software (NIH, Bethesda, MD, USA) was used to quantify the optical density value of each band. The sequences of specific primers (Sangon Biotech Inc., Shanghai, China) used for RT-PCR are listed in Table I.

Table I

Sequences of the primers and PCR product sizes used in RT-PCR.

Table I

Sequences of the primers and PCR product sizes used in RT-PCR.

GenePrimerSequenceSize (bp)
GAPDHSense 5′-AGAAGGCTGGGGCTCATTTG-3′258
Antisense 5′-AGGGGCCATCCACAGTCTTC-3′
BaxSense 5′-CCAAGGTGCCGGAACTGA-3′57
Antisense 5′-CCCGGAGGAAGTCCAATGT-3′
Bcl-2Sense 5′-CATGTGTGTGGAGAGCGTCAAC-3′187
Antisense 5′-CTTCAGAGACAGCCAGGAGAAATC-3′

[i] GAPDH, glyceraldehyde 3-phosphate dehydrogenase; Bax, Bcl-2-associated X protein; Bcl-2, B cell lymphoma-2.

Western blot analysis

Cells were collected at 24 h after exposure to H2O2. In order to detect the expression of Bcl-2 and Bax, SK-N-SH cells were washed with PBS and lysed using a lysis buffer for 30 min on ice. Lysates were centrifuged at 16,000 × g for 10 min at 4°C, and the supernatant was saved for the total protein determination. Protein concentrations were determined using a commercially available BCA protein assay kit (Beyotime Biotechnology). For western blot analysis, equivalent amounts of protein of each sample (20 µg) were electrophoresed using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and transferred to polyvinylidene difluoride membranes (Millipore, Bedford, MA, USA). After the membranes were blocked with 5% non-fat dry milk in Tris-buffered saline (TBS) for 1 h at room temperature, primary antibodies (in TBST-5% BSA) against Bcl-2 (1:2,000; 12789-1-AP) and Bax (1:5,000; 60267-1-Ig) (both from ProteinTech Group Inc, Chicago, IL, USA) were added and incubated overnight at 4°C for determining signal transduction events. The membranes were rinsed three times with TBST and incubated with an appropriate HRP-conjugated secondary antibody (1:2,000; #04-15-06 and #04-18-06) (both from KPL, Gaithersburg, MD, USA) for 1 h at 37°C. An ECL kit (Millipore) was used to visualize membrane immunoreactivity. Quantification was performed using a computerized imaging program Quantity One (Bio-Rad, Hercules, CA, USA).

Statistical analysis

All data are presented as mean ± standard deviation of the mean (SD). Statistical analyses were performed by one-way analysis of variance (ANOVA) with post hoc Tukey's t-test to determine statistical significance. A value of P<0.05 was considered to indicated statistically significant differences.

Results

Morroniside attenuates H2O2-induced cell death

H2O2-induced cell injury was evaluated using the MTT assay. H2O2 reduced cell viability in a dose- and time-dependent manner, with a survival rate of 50% after 24 h in the presence of 200 µM H2O2 relative to the untreated controls (Fig. 2A). Cells were treated with various concentrations of morroniside for 24 h to determine whether the H2O2-induced decrease in viability would be mitigated. Morroniside had no effect on the survival of SK-N-SH cells that were not treated with H2O2 (Fig. 2B). However, pretreatment with morroniside attenuated the H2O2-induced decrease in cell survival in a dose-dependent manner, with the greatest effect observed at 10 µM (Fig. 2C).

Figure 2

(A) Effects of H2O2 on SK-N-SH cell viability. Cell viability was reduced in a dose- and time-dependent manner by treatment with H2O2 (200 µM for 24). (B) Effects of morroniside on SK-N-SH cell viability. Morroniside treatment did not affect cell viability at concentrations of 1, 10 and 100 µM. (C) Effects of morroniside on H2O2-induced SK-N-SH cell death. Pretreatment with morroniside (1–100 µM) for 24 h restored viability in cells exposed to H2O2 (200 µM) in a dose-dependent manner. (D) Morroniside inhibits morphological changes resulting from H2O2 treatment. Scale bar, 20 µM. (E) Morroniside suppresses H2O2-induced lactate dehydrogenase (LDH) release in SK-N-SH cells. Cells were pretreated with indicated concentrations of morroniside (1–100 µM) for 24 h following treatment with 200 µM H2O2 or no treatment for 24 h. LDH activity in the medium was measured. Data represent mean ± SD (n=3). #P<0.05, ##P<0.01 and ###P<0.001 vs. control group; **P<0.01 and ***P<0.001 vs. H2O2-treated group.

Morroniside reverses H2O2-induced morphological changes

SK-N-SH cells treated for 24 h with 200 µM H2O2 showed morphological changes including loss of cell projections; a round, swollen, or shrunken cell body; and aggregation. These changes were blocked by pretreatment with morroniside (Fig. 2D).

Morroniside inhibits H2O2-induced LDH release

The LDH release assay showed that H2O2 increased LDH activity in the supernatant of the SK-N-SH cell cultures relative to the control group. This effect was suppressed upon treatment with 1, 10 and 100 µM morroniside (P<0.05) (Fig. 2E).

Morroniside protects SK-N-SH cells from H2O2-induced apoptosis

We investigated whether the H2O2-induced decrease in SK-N-SH cell survival was due to apoptosis by Hoechst 33342 and Annexin V/PI staining. Control cells stained with Hoechst 33342 had large, oval-shaped nuclei (Fig. 3A). H2O2 (200 µM) treatment increased the fraction of cells with condensed or fragmented nuclei (18.60±1.67 vs. 2.00±1.00%; P<0.01) (Fig. 3B and F). These defects were rescued by pretreatment with morroniside (1, 10 and 100 µM), which reduced the fraction of apoptotic cells (14.80±0.84, 10.40±1.14 and 13.20±1.48%, respectively vs. 18.60±1.67%; P<0.01) (Fig. 3C–F). Consistent with these findings, there were few cells positive for Annexin V/PI staining detected in the control group (Fig. 3G). H2O2 (200 µM) treatment increased the percentage of Annexin V+/PI+ cells (34.58±4.59 vs. 4.96±2.44%; P<0.001) (Fig. 3H and L), which was reduced by morroniside (1, 10 and 100 µM) treatment (26.86±4.05, 22.42±2.81 and 22.62±2.48%, respectively vs. 34.58±4.59%; P<0.05) (Fig. 3I–L).

Figure 3

Morroniside blocks H2O2-induced apoptosis of SK-N-SH cells. Apoptotic nuclei were visualized by Hoechst 33342 staining. (A) Untreated cells with normal nuclei. (B) Cells exposed to 200 µM H2O2 with condensed nuclei. (C–E) Cells pretreated with morroniside at concentrations of (C) 1 µM, (D) 10 µM and (E) 100 µM for 24 h showed reduced sensitivity to the effects of H2O2, as evidenced by fewer cells with condensed nuclei. Scale bar, 20 µM. (G–K) Annexin V/propidium iodide (PI) double-staining was used to confirm apoptosis in SK-N-SH cells. Few cells positive for Annexin V/PI staining were detected in the control group (G), while H2O2 (200 µM) treatment increased the percentage of Annexin V+/PI+ cells (H). Preincubation with (I) 1 µM, (J) 10 µM and (K) 100 µM morroniside for 24 h inhibited H2O2-induced apoptosis. Quantitative analyses are shown in panels (F and L). Data represent mean ± SD of three independent experiments. ###P<0.001 vs. control group; *P<0.01, **P<0.01 and ***P<0.001 vs. injury group.

Morroniside inhibits H2O2-induced elevation in intracellular ROS level

Intracellular ROS levels were detected with 2,7′-dichlorofluorescein (DCF) diacetate. SK-N-SH cells exposed to 200 and 400 µM H2O2 for 24 h showed dose-dependent increases in intracellular DCF fluorescence (P<0.01) (Fig. 4A–C and G), indicating that ROS levels were elevated. However, 10 µM morroniside pretreatment abrogated these increases in fluorescence intensity compared to the H2O2-treated groups (P<0.01) (Fig. 4E–G), suggesting a protective effect against H2O2-induced free radical formation.

Figure 4

Morroniside attenuates H2O2-induced accumulation of intracellular reactive oxygen species (ROS) in SK-N-SH cells. Cells were pretreated with (D–F) 10 µM morroniside for 24 h followed by (B and E) 200 µM or (C and F) 400 µM H2O2 for 24 h. Untreated control cells are shown in (A). ROS levels were increased in a dose-dependent manner by treatment with (B) 200 µM and (C) 400 µM H2O2. The increase was abolished by pretreatment with 10 µM morroniside (E and F). Intracellular superoxide anion levels were measured by dihydroethidium staining. Compared to the control (H), H2O2 (200 µM) increased superoxide anion production (I), an effect that was reversed by pretreatment with (J) 1 µM, (K) 10 µM and (L) 100 µM morroniside. Quantitative analyses are shown (G and M). Data represent mean ± SD of three independent experiments. ##P<0.01 and ###P<0.001 vs. control group; *P<0.01, **P<0.01 and ***P<0.001 vs. injury group. Scale bars: (F) 50 µM and (L) 20 µM.

Superoxide anion is a type of ROS that is associated with oxidative stress. To determine whether it is involved in H2O2-induced cytotoxicity, we measured intracellular superoxide anion levels with the dihydroethidium probe (Fig. 4H–M). The fluorescence intensity of SK-N-SH cells increased markedly after incubation for 24 h with H2O2 (P<0.001) (Fig. 4I and M). However, pretreatment with 1, 10 and 100 µM morroniside significantly reduced intracellular superoxide anion levels.

Morroniside suppresses H2O2-induced lipid peroxidation

Lipid peroxidation levels were monitored by detecting the stable end products of lipid peroxidation using an MDA assay kit. Under normal conditions, cellular MDA content was ~119.47±14.14 nmol/g protein (Fig. 5). In cells treated with 200 µM H2O2 for 24 h, the level was increased to 296.28±24.25 nmol/g protein (P<0.001). However, pretreatment with 1, 10 and 100 µM morroniside reduced MDA levels to 256.26±6.70, 223.63±12.47 and 224.35±10.18 nmol/g protein, respectively (P<0.05).

Figure 5

Effect of morroniside on H2O2-induced lipid oxidation. Cells were pretreated with indicated concentrations of morroniside for 24 h followed by 200 µM H2O2 for 24 h. Data represent mean ± SD of three independent experiments. ###P<0.001 vs. control group; *P<0.01 and **P<0.01 vs. injury group.

Morroniside inhibits H2O2-induced SOD depletion

To investigate the antioxidant properties of morroniside, we measured intracellular levels of SOD. Treatment with 200 µM H2O2 for 24 h reduced intracellular SOD levels from 6.77±0.45 to 3.74±0.41 U/mg (P<0.001). This was reversed by morroniside pretreatment at concentrations ranging from 1 to 100 µM; for example, a concentration of 10 µM enhanced SOD level by over 45% relative to the H2O2-treated group (Fig. 6).

Figure 6

Morroniside blocks the H2O2-induced decrease in superoxide dismutase (SOD) level in SK-N-SH cells. Cells were pre-incubated with 1, 10 or 100 µM morroniside for 24 h followed by H2O2 for 24 h. Data represent mean ± SD of three independent experiments. ###P<0.001 vs. control group; *P<0.01 and **P<0.01 vs. injury group.

Morroniside suppresses H2O2-induced decreases in MMP

We investigated whether morroniside could suppress the H2O2-induced decrease in MMP using JC-1 dye. SK-N-SH cells treated with 200 µM H2O2 for 24 h showed an obvious decrease in MMP, as evidenced by a decrease in the ratio of red to green fluorescence (Fig. 7). This effect was mitigated by treatment with morroniside, most obviously at a concentration of 10 µM.

Figure 7

Inhibition of H2O2-induced reduction in mitochondrial membrane potential (MMP) by morroniside. (A and B) Cells were pretreated with the indicated concentrations of morroniside followed by 200 µM H2O2. The decrease in MMP was quantified with JC-1 staining and fluorescence microscopy. Scale bar, 20 µM.

Morroniside inhibits H2O2-induced caspase-3 level

Caspase-3 is a key protein in the regulation of apoptosis. SK-N-SH cells treated with 200 µM H2O2 for 24 h showed a nearly 2-fold increase in the caspase-3 level relative to the control cells (P<0.01) (Fig. 8). Pretreatment with morroniside (1, 10 and 100 µM) suppressed the H2O2-induced upregulation of caspase-3 (3.77±0.31, 3.05±0.16 and 3.31±0.12 µM pNA/g, respectively vs. 4.91±0.36 µM pNA/g; P<0.05).

Figure 8

Effect of morroniside on caspase-3 activity. Cells were pretreated with indicated concentrations of morroniside for 24 h followed by H2O2 for 24 h. Data represent mean ± SD of four independent experiments. ##P<0.01 vs. control group; *P<0.01 and **P<0.01 vs. injury group.

Morroniside modulates expression of apoptosis-related proteins

The expression levels of the apoptosis-related genes Bcl-2 and Bax were altered in the SK-N-SH cells by H2O2 administration; the Bcl-2 mRNA level was downregulated while that of Bax was upregulated (Fig. 9A–C). These changes were abolished by pretreatment with 1–100 µM morroniside. Similarly, western blot analysis revealed that H2O2 (200 µM) decreased the Bcl-2 level (P<0.001) and increased that of Bax (P<0.01) after 24 h (Fig. 9D–F). However, pretreatment with 1, 10 and 100 µM morroniside restored Bcl-2 and Bax expression levels compared to these levels in the H2O2-induced group.

Figure 9

Effect of morroniside on the expression of apoptosis-related proteins. Cells were pretreated with the indicated concentrations of morroniside for 24 h followed by H2O2 for 24 h. Bcl-2 and Bax expression was evaluated by (A–C) RT-PCR and (D–F) western blotting. Values represent mean ± SD of three independent experiments. ##P<0.01 and ###P<0.001 vs. the control group; **P<0.01and ***P<0.001 vs. the injury group.

Discussion

Oxidative stress caused by ROS is implicated in the pathogenesis of most chronic diseases (23,24). ROS accumulation results in cellular damage (5). Loss of neurons due to oxidative stress plays a key role in the development of cerebrovascular and/or neurodegenerative diseases (1,8,25). Neurons are thought to be more susceptible to oxidative damage than other cell types due to their high oxygen consumption and low antioxidant capabilities (26). In the present study, we found that H2O2, a freely diffusible ROS, induced apoptosis in the human neuroblastoma SK-N-SH cells.

Usually, antioxidants, especially those derived from natural sources, have many therapeutic applications (27,28). Morroniside is a constituent of C. officinalis, a traditional Chinese medicine (29), and has demonstrated protective effects against cerebral ischemic damage (15), indicating a potential role of morroniside on restoring injured neurons. However, little is known concerning the underlying mechanisms. In this study, we investigated the neuroprotective role of morroniside in SK-N-SH cells treated with H2O2.

Exposure of cells to exogenous H2O2 can induce ROS overproduction (30), leading to peroxidation of membrane lipids and disruption of cellular integrity (31). The present study showed that pretreatment with morroniside reversed H2O2-induced apoptosis by blocking ROS production.

SOD is a component of the antioxidant machinery in neurons (32). In most situations, ROS produced through metabolic processes are quenched by intracellular defense systems, including SOD (33). Previous studies have shown that depletion of cellular glutathione leads to accumulation of ROS and mitochondrial dysfunction (34). We found here that morroniside treatment increased SOD activity in the SK-N-SH cells, which prevented ROS accumulation. Thus, we propose that the cytoprotective effects of morroniside are associated with its antioxidant capacity, for which, antioxidants such as glutathione or SOD are indispensable.

Overproduction of ROS disrupts the intracellular redox equilibrium, resulting in apoptosis (35). ROS target mitochondrial membrane proteins, leading to activation of the mitochondrial permeability transition pore, which decreases the MMP (36) and releases cytochrome c into the cytosol, where it binds to apoptotic protease activating factor 1 and forms the apoptosome, which activates pro-apoptotic caspases (37). Indeed, we observed that H2O2 treatment reduced the MMP and activated the pro-apoptotic protein caspase-3. These effects were blocked by pretreatment with morroniside, suggesting that morroniside exerts protective effects by blocking the mitochondrial apoptotic pathway.

H2O2 has been reported to modulate the levels of Bcl-2 and Bax, two genes associated with mitochondrial apoptosis, in various cell types including cortical neurons (30), endothelial cells (38), and HT22 cells (39), specifically by suppressing Bcl-2 and stimulating Bax expression (30). This was observed in our study at both the mRNA and protein levels following administration of H2O2 for 24 h. Moreover, morroniside treatment reversed the changes in Bcl-2 and Bax expression induced by H2O2. The pro-apoptotic protein Bax is activated during apoptosis, and its relocation from the cytoplasm to the mitochondrial outer membrane leads to formation of the mitochondrial permeability transition pore and downstream events. Bax accumulated in the mitochondrial outer membrane binds to the anti-apoptotic protein Bcl-2 and maintains it in an inactive state (37). Bcl-2 also acts as an antioxidant by suppressing ROS levels and the mitochondrial apoptosis pathway (40). Taken together, these findings suggest that morroniside blocks mitochondrial apoptosis via modulation of Bcl-2 and Bax expression.

In conclusion, in the present study, morroniside was found to protect against H2O2-induced oxidative damage in SK-N-SH neuronal cells. This effect was mediated by inhibition of ROS-induced oxidative stress as well as suppressing and stimulating Bax and Bcl-2 expression, respectively, leading to inhibition of the mitochondrial apoptotic pathway. Thus, morroniside can potentially be used for the prevention and treatment of neurodegenerative diseases.

Acknowledgments

The present study was supported by the National Natural Science Foundation of China (no. 81471277) and the Program of Anhui Province for Academic and Technical Leader in University.

References

1 

Destée A, Mutez E, Kreisler A, Vanbesien-Maillot C and Chartier-Harlin MC: Parkinson disease: Genetics and neuronal death. Rev Neurol (Paris). 165:F80–F85. 2009.In French.

2 

Zeineddine R and Yerbury JJ: The role of macropinocytosis in the propagation of protein aggregation associated with neurodegenerative diseases. Front Physiol. 6:2772015. View Article : Google Scholar : PubMed/NCBI

3 

Jia Z, Zhu H, Li J, Wang X, Misra H and Li Y: Oxidative stress in spinal cord injury and antioxidant-based intervention. Spinal Cord. 50:264–274. 2012. View Article : Google Scholar

4 

Bains M and Hall ED: Antioxidant therapies in traumatic brain and spinal cord injury. Biochim Biophys Acta. 1822:675–684. 2012. View Article : Google Scholar

5 

Rodrigo R, Fernández-Gajardo R, Gutiérrez R, Matamala JM, Carrasco R, Miranda-Merchak A and Feuerhake W: Oxidative stress and pathophysiology of ischemic stroke: Novel therapeutic opportunities. CNS Neurol Disord Drug Targets. 12:698–714. 2013. View Article : Google Scholar : PubMed/NCBI

6 

Shirley R, Ord EN and Work LM: Oxidative stress and the use of antioxidants in stroke. Antioxidants Basel. 3:472–501. 2014. View Article : Google Scholar : PubMed/NCBI

7 

Dias V, Junn E and Mouradian MM: The role of oxidative stress in Parkinson's disease. J Parkinsons Dis. 3:461–491. 2013.PubMed/NCBI

8 

Lovell MA and Markesbery WR: Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease. Nucleic Acids Res. 35:7497–7504. 2007. View Article : Google Scholar : PubMed/NCBI

9 

Khojah HM, Ahmed S, Abdel-Rahman MS and Hamza AB: Reactive oxygen and nitrogen species in patients with rheumatoid arthritis as potential biomarkers for disease activity and the role of antioxidants. Free Radic Biol Med. 97:285–291. 2016. View Article : Google Scholar : PubMed/NCBI

10 

Dröge W: Free radicals in the physiological control of cell function. Physiol Rev. 82:47–95. 2002. View Article : Google Scholar : PubMed/NCBI

11 

Turrens JF: Mitochondrial formation of reactive oxygen species. J Physiol. 552:335–344. 2003. View Article : Google Scholar : PubMed/NCBI

12 

Lee HG and Yang JH: PKC-δ mediates TCDD-induced apoptosis of chondrocyte in ROS-dependent manner. Chemosphere. 81:1039–1044. 2010. View Article : Google Scholar : PubMed/NCBI

13 

Hamann K, Durkes A, Ouyang H, Uchida K, Pond A and Shi R: Critical role of acrolein in secondary injury following ex vivo spinal cord trauma. J Neurochem. 107:712–721. 2008. View Article : Google Scholar : PubMed/NCBI

14 

Hamann K and Shi R: Acrolein scavenging: A potential novel mechanism of attenuating oxidative stress following spinal cord injury. J Neurochem. 111:1348–1356. 2009. View Article : Google Scholar : PubMed/NCBI

15 

Li X, Huo C, Wang Q, Zhang X, Sheng X and Zhang L: Identification of new metabolites of morroniside produced by rat intestinal bacteria and HPLC-PDA analysis of metabolites in vivo. J Pharm Biomed Anal. 45:268–274. 2007. View Article : Google Scholar : PubMed/NCBI

16 

Park CH, Noh JS, Kim JH, Tanaka T, Zhao Q, Matsumoto K, Shibahara N and Yokozawa T: Evaluation of morroniside, iri glycoside from Corni Fructus, on diabetes-induced alterations such as oxidative stress, inflammation, and apoptosis in the liver of type 2 diabetic db/db mice. Biol Pharm Bull. 34:1559–1565. 2011. View Article : Google Scholar

17 

Ai HX, Wang W, Sun FL, Huang WT, An Y and Li L: Morroniside inhibits H2O2 cells. Zhongguo Zhong Yao Za Zhi -induced apoptosis in cultured nerve. 33:2109–2112. 2008.In Chinese.

18 

Jang SE, Jeong JJ, Hyam SR, Han MJ and Kim DH: Ursolic acid isolated from the seed of Cornus officinalis ameliorates colitis in mice by inhibiting the binding of lipopolysaccharide to Toll-like receptor 4 on macrophages. J Agric Food Chem. 62:9711–9721. 2014. View Article : Google Scholar : PubMed/NCBI

19 

Yu HH, Hur JM, Seo SJ, Moon HD, Kim HJ, Park RK and You YO: Protective effect of ursolic acid from Cornus officinalis on the hydrogen peroxide-induced damage of HEI-OC1 auditory cells. Am J Chin Med. 37:735–746. 2009. View Article : Google Scholar : PubMed/NCBI

20 

Kim SH, Lee MK, Ahn M-J, Lee KY, Kim YC and Sung SH: Efficient method for extraction and simultaneous determination of active constituents in Cornus officinalis by reflux extraction and high performance liquid chromatography with diode array detection. J Liq Chromatogr Relat Technol. 32:822–832. 2009. View Article : Google Scholar

21 

Li CY, Li L, Li YH, Ai HX and Zhang L: Effects of extract from Cornus officinalis on nitric oxide and NF-kappaB in cortex of cerebral infarction rat model. Zhongguo Zhong Yao Za Zhi. 30:1667–1670. 2005.In Chinese.

22 

Hu JG, Fu SL, Zhang KH, Li Y, Yin L, Lu PH and Xu XM: Differential gene expression in neural stem cells and oligodendrocyte precursor cells: a cDNA microarray analysis. J Neurosci Res. 78:637–646. 2004. View Article : Google Scholar : PubMed/NCBI

23 

Rani V, Deep G, Singh RK, Palle K and Yadav UC and Yadav UC: Oxidative stress and metabolic disorders: Pathogenesis and therapeutic strategies. Life Sci. 148:183–193. 2016. View Article : Google Scholar : PubMed/NCBI

24 

Miranda-Díaz AG, Pazarín-Villaseñor L, Yanowsky-Escatel FG and Andrade-Sierra J: Oxidative stress in fiabetic nephropathy with early chronic kidney disease. J Diabetes Res. 2016:70472382016. View Article : Google Scholar

25 

Forte M, Conti V, Damato A, Ambrosio M, Puca AA, Sciarretta S, Frati G, Vecchione C and Carrizzo A: Targeting nitric oxide with natural derived compounds as a therapeutic strategy in vascular diseases. Oxid Med Cell Longev. 2016:73641382016. View Article : Google Scholar : PubMed/NCBI

26 

Karpinska A and Gromadzka G: Oxidative stress and natural antioxidant mechanisms: the role in neurodegeneration. From molecular mechanisms to therapeutic strategies. Postepy Higieny i Medycyny Doswiadczalnej (Online). 67:43–53. 2013. View Article : Google Scholar

27 

Turkez H, Sozio P, Geyikoglu F, Tatar A, Hacimuftuoglu A and Di Stefano A: Neuroprotective effects of farnesene against hydrogen peroxide-induced neurotoxicity in vitro. Cell Mol Neurobiol. 34:101–111. 2014. View Article : Google Scholar

28 

Tian LL, Wang XJ, Sun YN, Li CR, Xing YL, Zhao HB, Duan M, Zhou Z and Wang SQ: Salvianolic acid B, an antioxidant from Salvia miltiorrhiza, prevents 6-hydroxydopamine induced apoptosis in SH-SY5Y cells. Int J Biochem Cell Biol. 40:409–422. 2008. View Article : Google Scholar

29 

Ding X, Wang MY, Yu ZL, Hu W and Cai BC: Studies on separation, appraisal and the biological activity of 5-HMF in Cornus officinalis. Zhongguo Zhong Yao Za Zhi. 33:392–396. 4842008.In Chinese.

30 

Jiang X, Nie B, Fu S, Hu J, Yin L, Lin L, Wang X, Lu P and Xu XM: EGb 761 protects hydrogen peroxide-induced death of spinal cord neurons through inhibition of intracellular ROS production and modulation of apoptotic regulating genes. J Mol Neurosci. 38:103–113. 2009. View Article : Google Scholar : PubMed/NCBI

31 

Xu H, Shen J, Liu H, Shi Y, Li L and Wei M: Morroniside and loganin extracted from Cornus officinalis have protective effects on rat mesangial cell proliferation exposed to advanced glycation end products by preventing oxidative stress. Can J Physiol Pharmacol. 84:1267–1273. 2006. View Article : Google Scholar

32 

Hilton JB, White AR and Crouch PJ: Endogenous Cu in the central nervous system fails to satiate the elevated requirement for Cu in a mutant SOD1 mouse model of ALS. Metallomics. 8:1002–1011. 2016. View Article : Google Scholar : PubMed/NCBI

33 

Hwang KA, Hwang YJ and Song J: Antioxidant activities and oxidative stress inhibitory effects of ethanol extracts from Cornus officinalis on raw 264.7 cells. BMC Complement Altern Med. 16:1962016. View Article : Google Scholar : PubMed/NCBI

34 

Bharat S, Cochran BC, Hsu M, Liu J, Ames BN and Andersen JK: Pretreatment with R-lipoic acid alleviates the effects of GSH depletion in PC12 cells: Implications for Parkinson's disease therapy. Neurotoxicology. 23:479–486. 2002. View Article : Google Scholar : PubMed/NCBI

35 

Deng G, Su JH, Ivins KJ, Van Houten B and Cotman CW: Bcl-2 facilitates recovery from DNA damage after oxidative stress. Exp Neurol. 159:309–318. 1999. View Article : Google Scholar : PubMed/NCBI

36 

Nguyen TT, Stevens MV, Kohr M, Steenbergen C, Sack MN and Murphy E: Cysteine 203 of cyclophilin D is critical for cyclophilin D activation of the mitochondrial permeability transition pore. J Biol Chem. 286:40184–40192. 2011. View Article : Google Scholar : PubMed/NCBI

37 

Del Gaizo Moore V and Letai A: BH 3 profiling - measuring integrated function of the mitochondrial apoptotic pathway to predict cell fate decisions. Cancer Lett. 332:202–205. 2013. View Article : Google Scholar

38 

Li DW, Li JH, Wang YD and Li GR: Atorvastatin protects endothelial colony forming cells against H2O2 induced oxidative damage by regulating the expression of Annexin A2. Mol Med Rep. 12:7941–7948. 2015.PubMed/NCBI

39 

Xu H, Luo P, Zhao Y, Zhao M, Yang Y, Chen T, Huo K, Han H and Fei Z: Iduna protects HT22 cells from hydrogen peroxide-induced oxidative stress through interfering poly(ADP-ribose) polymerase-1-induced cell death (parthanatos). Cell Signal. 25:1018–1026. 2013. View Article : Google Scholar : PubMed/NCBI

40 

Neuzil J, Wang XF, Dong LF, Low P and Ralph SJ: Molecular mechanism of 'mitocan'-induced apoptosis in cancer cells epitomizes the multiple roles of reactive oxygen species and Bcl-2 family proteins. FEBS Lett. 580:5125–5129. 2006. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhang J, Wang R, Xi J, Shen L, Zhu A, Qi Q, Wang Q, Zhang L, Wang F, Lü H, Lü H, et al: Morroniside protects SK-N-SH human neuroblastoma cells against H2O2-induced damage Corrigendum in /10.3892/ijmm.2025.5501. Int J Mol Med 39: 603-612, 2017.
APA
Zhang, J., Wang, R., Xi, J., Shen, L., Zhu, A., Qi, Q. ... Hu, J. (2017). Morroniside protects SK-N-SH human neuroblastoma cells against H2O2-induced damage Corrigendum in /10.3892/ijmm.2025.5501. International Journal of Molecular Medicine, 39, 603-612. https://doi.org/10.3892/ijmm.2017.2882
MLA
Zhang, J., Wang, R., Xi, J., Shen, L., Zhu, A., Qi, Q., Wang, Q., Zhang, L., Wang, F., Lü, H., Hu, J."Morroniside protects SK-N-SH human neuroblastoma cells against H2O2-induced damage Corrigendum in /10.3892/ijmm.2025.5501". International Journal of Molecular Medicine 39.3 (2017): 603-612.
Chicago
Zhang, J., Wang, R., Xi, J., Shen, L., Zhu, A., Qi, Q., Wang, Q., Zhang, L., Wang, F., Lü, H., Hu, J."Morroniside protects SK-N-SH human neuroblastoma cells against H2O2-induced damage Corrigendum in /10.3892/ijmm.2025.5501". International Journal of Molecular Medicine 39, no. 3 (2017): 603-612. https://doi.org/10.3892/ijmm.2017.2882
Copy and paste a formatted citation
x
Spandidos Publications style
Zhang J, Wang R, Xi J, Shen L, Zhu A, Qi Q, Wang Q, Zhang L, Wang F, Lü H, Lü H, et al: Morroniside protects SK-N-SH human neuroblastoma cells against H2O2-induced damage Corrigendum in /10.3892/ijmm.2025.5501. Int J Mol Med 39: 603-612, 2017.
APA
Zhang, J., Wang, R., Xi, J., Shen, L., Zhu, A., Qi, Q. ... Hu, J. (2017). Morroniside protects SK-N-SH human neuroblastoma cells against H2O2-induced damage Corrigendum in /10.3892/ijmm.2025.5501. International Journal of Molecular Medicine, 39, 603-612. https://doi.org/10.3892/ijmm.2017.2882
MLA
Zhang, J., Wang, R., Xi, J., Shen, L., Zhu, A., Qi, Q., Wang, Q., Zhang, L., Wang, F., Lü, H., Hu, J."Morroniside protects SK-N-SH human neuroblastoma cells against H2O2-induced damage Corrigendum in /10.3892/ijmm.2025.5501". International Journal of Molecular Medicine 39.3 (2017): 603-612.
Chicago
Zhang, J., Wang, R., Xi, J., Shen, L., Zhu, A., Qi, Q., Wang, Q., Zhang, L., Wang, F., Lü, H., Hu, J."Morroniside protects SK-N-SH human neuroblastoma cells against H2O2-induced damage Corrigendum in /10.3892/ijmm.2025.5501". International Journal of Molecular Medicine 39, no. 3 (2017): 603-612. https://doi.org/10.3892/ijmm.2017.2882
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team